The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

The recall, according to a news release published Wednesday, involves Northwest Naturals' Feline Turkey Recipe raw frozen pet ...

CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...

Wexford’s Linda Kelly and Katie-George Dunlevy crowned RTÉ Sport Team of the Year – ‘For a para-athlete to win something like this, it’s huge’ ...

How is the 20 years of 2004 tsunami relevant to the UPSC exam? What significance do topics like the real effective exchange ...